vs
Apellis Pharmaceuticals, Inc.（APLS）与APOGEE ENTERPRISES, INC.（APOG）财务数据对比。点击上方公司名可切换其他公司
APOGEE ENTERPRISES, INC.的季度营收约是Apellis Pharmaceuticals, Inc.的1.8倍（$351.4M vs $199.9M），APOGEE ENTERPRISES, INC.净利率更高（4.7% vs -29.5%，领先34.2%），APOGEE ENTERPRISES, INC.同比增速更快（1.6% vs -5.9%），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 2.9%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Apogee Enterprises是一家美国音频设备制造商，主营音频接口、模数与数模转换器、USB及iOS麦克风，同时还开发音频制作相关软件，产品广泛服务于专业录音、音乐创作等音频领域，在全球音频行业拥有较高的认可度。
APLS vs APOG — 直观对比
营收规模更大
APOG
是对方的1.8倍
$199.9M
营收增速更快
APOG
高出7.5%
-5.9%
净利率更高
APOG
高出34.2%
-29.5%
两年增速更快
APLS
近两年复合增速
2.9%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $351.4M |
| 净利润 | $-59.0M | $16.6M |
| 毛利率 | — | 22.4% |
| 营业利润率 | -25.6% | 7.3% |
| 净利率 | -29.5% | 4.7% |
| 营收同比 | -5.9% | 1.6% |
| 净利润同比 | -62.2% | 568.8% |
| 每股收益（稀释后） | $-0.40 | $0.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSAPOG
| Q1 26 | — | $351.4M | ||
| Q4 25 | $199.9M | $348.6M | ||
| Q3 25 | $458.6M | $358.2M | ||
| Q2 25 | $178.5M | $346.6M | ||
| Q1 25 | $166.8M | $345.7M | ||
| Q4 24 | $212.5M | $341.3M | ||
| Q3 24 | $196.8M | $342.4M | ||
| Q2 24 | $199.7M | $331.5M |
净利润APLSAPOG
| Q1 26 | — | $16.6M | ||
| Q4 25 | $-59.0M | $16.5M | ||
| Q3 25 | $215.7M | $23.6M | ||
| Q2 25 | $-42.2M | $-2.7M | ||
| Q1 25 | $-92.2M | $2.5M | ||
| Q4 24 | $-36.4M | $21.0M | ||
| Q3 24 | $-57.4M | $30.6M | ||
| Q2 24 | $-37.7M | $31.0M |
毛利率APLSAPOG
| Q1 26 | — | 22.4% | ||
| Q4 25 | — | 23.8% | ||
| Q3 25 | — | 23.1% | ||
| Q2 25 | — | 21.7% | ||
| Q1 25 | — | 21.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 28.4% | ||
| Q2 24 | — | 29.8% |
营业利润率APLSAPOG
| Q1 26 | — | 7.3% | ||
| Q4 25 | -25.6% | 7.1% | ||
| Q3 25 | 48.7% | 7.5% | ||
| Q2 25 | -18.6% | 2.0% | ||
| Q1 25 | -50.0% | 1.8% | ||
| Q4 24 | -12.3% | 8.4% | ||
| Q3 24 | -24.0% | 12.3% | ||
| Q2 24 | -14.7% | 12.5% |
净利率APLSAPOG
| Q1 26 | — | 4.7% | ||
| Q4 25 | -29.5% | 4.7% | ||
| Q3 25 | 47.0% | 6.6% | ||
| Q2 25 | -23.6% | -0.8% | ||
| Q1 25 | -55.3% | 0.7% | ||
| Q4 24 | -17.1% | 6.1% | ||
| Q3 24 | -29.2% | 8.9% | ||
| Q2 24 | -18.9% | 9.4% |
每股收益（稀释后）APLSAPOG
| Q1 26 | — | $0.78 | ||
| Q4 25 | $-0.40 | $0.77 | ||
| Q3 25 | $1.67 | $1.10 | ||
| Q2 25 | $-0.33 | $-0.13 | ||
| Q1 25 | $-0.74 | $0.12 | ||
| Q4 24 | $-0.30 | $0.96 | ||
| Q3 24 | $-0.46 | $1.40 | ||
| Q2 24 | $-0.30 | $1.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $39.5M |
| 总债务越低越好 | — | $232.3M |
| 股东权益账面价值 | $370.1M | $511.8M |
| 总资产 | $1.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.45× |
8季度趋势，按日历期对齐
现金及短期投资APLSAPOG
| Q1 26 | — | $39.5M | ||
| Q4 25 | $466.2M | $41.3M | ||
| Q3 25 | $479.2M | $39.5M | ||
| Q2 25 | $370.0M | $32.8M | ||
| Q1 25 | $358.4M | $41.4M | ||
| Q4 24 | $411.3M | $43.9M | ||
| Q3 24 | $396.9M | $51.0M | ||
| Q2 24 | $360.1M | $30.4M |
总债务APLSAPOG
| Q1 26 | — | $232.3M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $285.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益APLSAPOG
| Q1 26 | — | $511.8M | ||
| Q4 25 | $370.1M | $512.3M | ||
| Q3 25 | $401.2M | $500.2M | ||
| Q2 25 | $156.3M | $481.8M | ||
| Q1 25 | $164.2M | $487.9M | ||
| Q4 24 | $228.5M | $522.1M | ||
| Q3 24 | $237.1M | $506.4M | ||
| Q2 24 | $264.3M | $480.0M |
总资产APLSAPOG
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $821.4M | $1.2B | ||
| Q1 25 | $807.3M | $1.2B | ||
| Q4 24 | $885.1M | $1.2B | ||
| Q3 24 | $901.9M | $917.1M | ||
| Q2 24 | $904.5M | $889.0M |
负债/权益比APLSAPOG
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $122.5M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | 7.8% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSAPOG
| Q1 26 | — | $122.5M | ||
| Q4 25 | $-14.2M | $29.3M | ||
| Q3 25 | $108.5M | $57.1M | ||
| Q2 25 | $4.4M | $-19.8M | ||
| Q1 25 | $-53.4M | $30.0M | ||
| Q4 24 | $19.4M | $31.0M | ||
| Q3 24 | $34.1M | $58.7M | ||
| Q2 24 | $-8.3M | $5.5M |
自由现金流APLSAPOG
| Q1 26 | — | — | ||
| Q4 25 | $-14.3M | $22.9M | ||
| Q3 25 | $108.3M | $52.4M | ||
| Q2 25 | $4.4M | $-26.9M | ||
| Q1 25 | $-53.4M | $19.1M | ||
| Q4 24 | $19.3M | $22.0M | ||
| Q3 24 | — | $50.2M | ||
| Q2 24 | $-8.4M | $-1.8M |
自由现金流率APLSAPOG
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | 6.6% | ||
| Q3 25 | 23.6% | 14.6% | ||
| Q2 25 | 2.5% | -7.8% | ||
| Q1 25 | -32.0% | 5.5% | ||
| Q4 24 | 9.1% | 6.4% | ||
| Q3 24 | — | 14.7% | ||
| Q2 24 | -4.2% | -0.5% |
资本支出强度APLSAPOG
| Q1 26 | — | 7.8% | ||
| Q4 25 | 0.1% | 1.9% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 0.0% | 2.1% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.0% | 2.6% | ||
| Q3 24 | 0.0% | 2.5% | ||
| Q2 24 | 0.0% | 2.2% |
现金转化率APLSAPOG
| Q1 26 | — | 7.37× | ||
| Q4 25 | — | 1.77× | ||
| Q3 25 | 0.50× | 2.41× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 12.08× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 1.92× | ||
| Q2 24 | — | 0.18× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
